Methanex (MEOH) reported $896 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.2%. EPS of $1.30 for the same period compares to $0.65 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.04 billion, representing a surprise of -13.80%. The company delivered an EPS surprise of +4.00%, with the consensus EPS estimate being $1.25. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Methanex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Sales volume in tonnes - Methanex-produced methanol: 1,703 KTon versus 1,800.93 KTon estimated by three analysts on average. Average realized methanol price ($/tonne): 404 $/Ton versus the three-analyst average estimate of 399.32 $/Ton. Sales volume in tonnes - Total: 2,217 KTon versus 2,599.33 KTon estimated by three analysts on average. Sales volume in tonnes - Commission sales: 132 KTon compared to the 149.33 KTon average estimate based on three analysts. Sales volume in tonnes - Purchased methanol: 382 KTon compared to the 649.06 KTon average estimate based on three analysts. Production in tonnes - Total: 1,619 KTon versus the two-analyst average estimate of 1,908.27 KTon. Operating Capacity - USA (Geismar): 1,000 KTon versus 1,450 KTon estimated by two analysts on average. Operating Capacity - New Zealand: 215 KTon compared to the 320 KTon average estimate based on two analysts. Operating Capacity - Chile: 425 KTon versus the two-analyst average estimate of 425 KTon. Operating Capacity - Egypt (50% interest): 158 KTon versus 157 KTon estimated by two analysts on average. Operating Capacity - Canada (Medicine Hat): 140 KTon compared to the 150 KTon average estimate based on two analysts. Production in tonnes - Canada (Medicine Hat): 140 KTon versus 138.72 KTon estimated by two analysts on average. View all Key Company Metrics for Methanex here>>> Shares of Methanex have returned -7.5% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Story Continues Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Methanex Corporation (MEOH):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Methanex (MEOH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...